Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today presents preclinical data on the mechanism by which IMO-2125 was shown to induce immune ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE